WHICH IS MORE BENEFICIAL AS AN INITIAL THERAPY FOR THE FIRST DISTANT METASTASIS OF BREAST CANCER: CHEMOTHERAPY OR ENDOCRINE THERAPY FOR HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE BREAST CANCER PATIENTS? A SINGLE-CENTER STUDY
The Breast（2015）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要